Cargando…

Efficacy of Paxlovid and Lagevrio for COVID-19 Infection in Patients With Inflammatory Bowel Disease: A Propensity-Matched Study

Detalles Bibliográficos
Autores principales:	Hashash, Jana G., Desai, Aakash, Kochhar, Gursimran S., Farraye, Francis A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the AGA Institute 2023
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492393/ https://www.ncbi.nlm.nih.gov/pubmed/36152898 http://dx.doi.org/10.1016/j.cgh.2022.09.011

Ejemplares similares

Tixagevimab and Cilgavimab (Evusheld) as Pre-exposure Prophylaxis for COVID-19 in Patients With Inflammatory Bowel Disease: A Propensity Matched Cohort Study
por: Desai, Aakash, et al.
Publicado: (2023)

COVID-19 breakthrough infections and sleep disorders: A population-based propensity matched analysis
por: Punj, Mantavya, et al.
Publicado: (2023)

On-site Availability Improves Vaccination Rates in Patients With Inflammatory Bowel Disease
por: Hashash, Jana G, et al.
Publicado: (2021)

Health Maintenance for Adult Patients with Inflammatory Bowel Disease
por: Hashash, Jana G., et al.
Publicado: (2021)

Efficacy and safety of vedolizumab in elderly patients with inflammatory bowel disease: a matched case–control study
por: Shashi, Preeti, et al.
Publicado: (2019)

Endoscopic Stricturotomy Is an Efficacious Option for Management of Strictures in Patients With Inflammatory Bowel Disease
por: Mohy-ud-din, Nabeeha, et al.
Publicado: (2020)

Development of Inflammatory Bowel Disease in HIV Patients: A Danish Cohort Study (1983–2018) With American Validation (1999–2018)
por: Elmahdi, Rahma, et al.
Publicado: (2022)

Association of serum IgG4 and disease outcomes in patients with inflammatory bowel disease
por: Chase, R. Christopher, et al.
Publicado: (2023)

DRUG INTERACTION BETWEEN PAXLOVID AND TACROLIMUS IN AN ADOLESCENT WITH INFLAMMATORY BOWEL DISEASE
por: Zaarur, Leenoy, et al.
Publicado: (2023)

Efficacy and safety of Paxlovid for COVID-19:a meta-analysis
por: Zheng, Qian, et al.
Publicado: (2023)

Clinical efficacy, timing, and outcomes of ERCP for management of bile duct leaks: a nationwide cohort study
por: Desai, Aakash, et al.
Publicado: (2021)

Clinical efficacy, timing, and outcomes of ERCP for management of bile duct leaks: a nationwide cohort study
por: Desai, Aakash, et al.
Publicado: (2021)

Drug Interaction Between Tacrolimus and Paxlovid (Nirmatrelvir/Ritonavir) in an Adolescent with Inflammatory Bowel Disease
por: Zaarur, Leenoy, et al.
Publicado: (2023)

Efficacy of Paxlovid in patients with acute kidney injury who developed COVID-19
por: Cai, Hong, et al.
Publicado: (2022)

Elevated troponin levels predict the reduced efficacy of Paxlovid in COVID-19 patients
por: Zhao, Deze, et al.
Publicado: (2023)

Safety and Effectiveness of Molnupiravir (LAGEVRIO(®)) Capsules in Japanese Patients with COVID-19: Interim Report of Post-marketing Surveillance in Japan
por: Kimata, Masahiro, et al.
Publicado: (2023)

Patterns of endoscopy during COVID-19 pandemic: a global survey of interventional inflammatory bowel disease practice
por: Chen, Yan, et al.
Publicado: (2021)

A Cohort Study of the Age at Menopause in Female Patients With and Without Inflammatory Bowel Disease
por: Moktan, Varun P, et al.
Publicado: (2022)

The Path to Paxlovid
por: Halford, Bethany
Publicado: (2022)

Inflammatory bowel disease in Lebanon: a plea for help
por: Mourad, Fadi H, et al.
Publicado: (2022)

Inflammatory Bowel Disease: An Indication to Screen for Thrombophilia?
por: Moukalled, Nour M., et al.
Publicado: (2022)

Generalized use of Nirmatrelvir plus ritonavir (Paxlovid): Raising concerns
por: Sánchez Fabra, David, et al.
Publicado: (2023)

Projected COVID-19 Mortality Reduction From Paxlovid Rollout
por: Khunte, Mihir, et al.
Publicado: (2023)

Generalized use of Nirmatrelvir plus ritonavir (Paxlovid): Raising concerns
por: Sánchez Fabra, David, et al.
Publicado: (2023)

Oral Contraceptive Pills Are an Effective Method of Preventing Pregnancy in Women With Crohn’s Disease
por: Daoud, Nader D, et al.
Publicado: (2021)

Roles of Clinical Pharmacists in Caring for Patients With Inflammatory Bowel Disease During COVID-19
por: Bhat, Shubha, et al.
Publicado: (2021)

Risk of Severe Coronavirus Disease 2019 in Patients With Inflammatory Bowel Disease in the United States: A Multicenter Research Network Study
por: Singh, Shailendra, et al.
Publicado: (2020)

Time to Flexible Sigmoidoscopy or Colonoscopy in Patients Admitted With Ulcerative Colitis Has Decreased From 2012 to 2018
por: Bali, Aman S, et al.
Publicado: (2021)

The future of Paxlovid for COVID-19
por: Burki, Talha
Publicado: (2022)

Ranolazine Toxicity Secondary to Paxlovid
por: Casey, Bradley, et al.
Publicado: (2023)

Impact of Paxlovid on international normalized ratio among patients on chronic warfarin therapy
por: Muse, Oluwatoyosi, et al.
Publicado: (2022)

Paxlovid with Caution: Novel Case of Paxlovid-Induced Tacrolimus Toxicity in a Cardiac Transplant Patient
por: Shah, Aaisha, et al.
Publicado: (2022)

Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period
por: Iacucci, Marietta, et al.
Publicado: (2020)

Propensity matching cannot substitute for randomization in albumin studies
por: Wiedermann, Christian J, et al.
Publicado: (2015)

Use of Standardized Inflammatory Bowel Disease Endoscopy Scores in Clinical Practice
por: Gaidos, Jill K J, et al.
Publicado: (2023)

Ethnic Variation Trends in the Use of Ileal Pouch–Anal Anastomosis in Patients With Ulcerative Colitis
por: Hashash, Jana G, et al.
Publicado: (2023)

Paxlovid™ jetzt direkt an Patienten abgeben
por: Zimmermann, Gerd W.
Publicado: (2022)

Paxlovid-Induced Symptomatic Bradycardia and Syncope
por: Ganipisetti, Venu M, et al.
Publicado: (2023)

CARDIOGENIC SHOCK DUE TO PAXLOVID INTERACTION
por: Enstrom, Cate, et al.
Publicado: (2023)

Serotonin Syndrome Precipitated by Paxlovid Initiation
por: Nasser, Nicholas G, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g2t8jvg73sm92jdsr90ecp82ks